leukapheresis
Showing 26 - 50 of 906
Mantle Cell Lymphoma Trial in Saint Louis (Bendamustine, Rituximab, Acalabrutinib)
Active, not recruiting
- Mantle Cell Lymphoma
- Bendamustine
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 2, 2022
Follicular Lymphoma Trial in Saint Louis (biological, drug, procedure)
Suspended
- Follicular Lymphoma
- Personalized tumor vaccine
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2021
Hematologic Malignancy, Haplo-identical Stem Cell Transplantation Trial (CD45RAneg cells, prepared from mononuclear cell
Not yet recruiting
- Hematologic Malignancy
- Haplo-identical Stem Cell Transplantation
- CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology
- (no location specified)
Oct 1, 2021
B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Autologous Anti-CD19 CAR-expressing T Lymphocytes
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 30, 2023
Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +3 more
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 13, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023
Glioblastoma Trial in Saint Louis (NeoVax, Nivolumab, Ipilimumab)
Terminated
- Glioblastoma
- NeoVax
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2021
Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,
Not yet recruiting
- Fallopian Tube Carcinosarcoma
- +14 more
- Biopsy
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 28, 2023
Prospective Tissue Collection Research Protocol
Recruiting
- Solid Tumor
- Tumour tissue collection
-
New York, New York
- +17 more
Jan 16, 2023
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
-
Atlanta, Georgia
- +2 more
Feb 9, 2022
Relapsed B-Cell Acute Lymphoblastic Leukemia Trial in Boston, New York (procedure, drug, biological)
Active, not recruiting
- Relapsed B-Cell Acute Lymphoblastic Leukemia
- leukapheresis or collection of PBMCs
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2022
Relapsed or Refractory Neuroblastoma Trial in London (other, drug, genetic)
Completed
- Relapsed or Refractory Neuroblastoma
- Leukapheresis
- +3 more
-
London, United KingdomUniversity College London Institute of Child Health & Great Ormo
Jul 23, 2021
HIV Persistence in Lymph Node and Peripheral Blood
Completed
- HIV-1-infection
- Leukapheresis
- Lymph node biopsy
-
Melbourne, Victoria, AustraliaAlfred Hospital
Jun 22, 2021
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Bone Marrow Aspiration
- +10 more
-
Los Angeles, CaliforniaMelanie Ayala Ceja
Jul 10, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 3, 2022
Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Diffuse Hemispheric Glioma, H3 G34-Mutant
- Dendritic Cell Tumor Peptide Vaccine
- +6 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)
Active, not recruiting
- COL6A3 Positive
- +3 more
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Generation of Antigen-specific T-lymphocyte Cell Lines From
Terminated
- Healthy
- Leukapheresis
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2021
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin
Not yet recruiting
- High Grade B-Cell Non-Hodgkin's Lymphoma
- +3 more
- Anti-CD19-CAR CMV-specific T-lymphocytes
- +9 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023